Rob Lenz

Rob Lenz

Head of Research and DevelopmentatNeumora Therapeutics· In the 2023 proxy

Pay in FY2023

Rob Lenz was paid $13.6M in FY2023 (Dec).

PayNo stock prices for these years
Pay is from the Summary Compensation Table of each Neumora Therapeutics proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. Neumora TherapeuticsPublic company · 3 yr
    • Head of Research and Development2023 – Present · 3 yrStock in role -98%

Roles come from the proxy statements of each company.

Activity

No new filings about this person in the feed.

Two people shown as one, or a wrong number?